LOS ANGELES (TheWrap.com) - Fresh off a guest-starring run as vampire Roman Zimojic in HBO's "True Blood," Christopher Meloni is ready to "Suck" again - this time for Fox.

"Law & Order: SVU" star Meloni has been cast in an adaptation of Justin Halpern's book "I Suck at Girls," which has received a pilot order from Fox.

The untitled project, which is being written and executive produced by Halpern and Patrick Schumacker, is about a boy becoming a man, and a man becoming a father, in a time before coming of age was something you could Google.

Meloni will play Jack Dunlevy, a straight-talking ex-military man and an oncologist who "talks to everyone like they're 75 years old and dying of cancer," the network said. Dunlevy's habit has been to go to work early, come home late, yell at his kids and go to bed, but he's forced to take a more active role in his kids' lived after his wife enrolls in law school.

Bill Lawrence and Jeff Ingold are also executive producing the half-hour, single-camera comedy, which comes from the Doozer production company in association with Warner Bros. Television.

Victor Nelli ("GCB," "Wilfred") is directing.

The study published by pharmaceutical intelligence firm IMS Health said the slowdown in France contrasts with slight increases seen in other mature markets, such as the United States, Japan and Germany, and with growth of over 10 percent expected in China and Brazil.

But it is less steep a decline than in austerity-hit southern Europe, while spending in France could be pushed up when new, innovative treatments which lack generic replacements reach the market from next year, the study said.

The market for drugs sold in French pharmacies is expected to drop by 3.4 percent this year, after sliding 2.3 percent in 2012 - its first yearly decline on record - as the government slashed healthcare spending through price cuts on branded drugs and favored prescriptions of cheaper generic drugs.

France is Europe's second-largest drug market after Germany and the pharmaceutical industry is the fourth-largest contributor to the country's trade balance, and one of the few sectors with a trade surplus.

Sanofi SA, the country's largest drugmaker, said in February the impact from government cutbacks on its earnings last year totaled 300 million euros ($388.7 million) and was expected to reach the same level in 2013.

The company warned that earnings could fall in 2013 as it continues to feel the effect of generic competition, but it expects to growth in subsequent years, driven by emerging markets, diabetes, vaccines, animal health, its takeover of biotechnology company Genzyme and new products.

($1 = 0.7717 euros)

(Reporting by Elena Berton; Editing by David Holmes)

SAN FRANCISCO (Reuters) - Oracle Corp blamed its rapidly expanding salesforce for a severe miss in third-quarter software sales and warned that its ailing hardware business will lose more ground this quarter, driving its shares 8 percent lower on Wednesday.

The world's No. 3 software maker projected a 1 to 11 percent rise in new software licenses and Internet-based subscriptions in the May quarter - an indicator of future performance. But investors focused on a 2 percent slip in the February quarter that badly missed Wall Street's targets.

Oracle's February quarter revenue miss was its worst since the November quarter of 2011.

"What we really saw was the lack of urgency we sometimes see in the sales force, as Q3 deals fall into Q4," Chief Financial Officer Safra Catz told analysts on a conference call.

"Since we've been adding literally thousands of new sales reps around the world, the problem was largely sales execution, especially with the new reps as they ran out of runway in Q3."

Wall Street remains concerned about tepid spending by governments and corporations in an uncertain global environment, but Catz dismissed those fears.

Oracle is also struggling with its hardware division and facing greater competition in cloud or Internet-based software from the likes of International Business Machines Corp and SAP AG and nimbler rivals like Salesforce Inc and Workday Inc.

Oppenheimer analyst Brian Schwartz said Oracle's May-quarter software sales projection was in line with expectations.

"That's probably a little hint that they've gotten off to a good start in Q4, that some of those deals that slipped in Q3 likely closed in Q4," Schwartz said.

WHITHER HARDWARE

Some investors still worry that governments and corporations around the globe may postpone spending on technology projects because of uncertainty over the economy, particularly in Europe.

"Business sentiment and confidence is way down. People are more cautious right now in business than they are in the stock market. That's how we get very high valuation multiples on stocks, but businesses are pulling back," said Richard Williams, an analyst at Cross Research.

Revenue from Oracle's hardware division, which it acquired through the $5.6 billion purchase of Sun Microsystems in 2010, fell to $671 million from $869 million in the year-ago quarter.

The division's revenue has fallen every quarter since it closed the Sun deal and Chief Executive Larry Ellison had said in December he expected hardware systems revenue to start growing in the fiscal fourth quarter.

Oracle projected its hardware product revenue for the current quarter would fall between 12 and 22 percent.

"There are areas that continue to be in transition, like the hardware business and the overall move to the cloud," said FBR Capital Markets analyst Daniel Ives. "They obviously hit a speed bump but the company is cautiously optimistic."

Oracle posted a 2 percent drop in new software sales and Internet-based software subscriptions to $2.3 billion in its fiscal third quarter. Investors scrutinize new software sales because they generate high-margin, long-term maintenance contracts and are an important barometer of future profit.

"It doesn't help that the sequester deadline is on the last day of our quarter, and so that has a little bit of an impact here in North America, but not necessarily anywhere else," Catz said. "The economy has been as it is in Europe for a while."

Oracle's revenue miss - about 4.4 percent below the average forecast - was its worst since the November quarter of 2011, when it fell short of target by 4.5 percent, according to Thomson Reuters data.

Next week, Oracle will start deliveries of its latest generation of servers, built with a record-breaking microprocessor, Ellison said.

Overall, Oracle's revenue dipped 1 percent to $9 billion, missing the $9.382 billion analysts had expected on average according to Thomson Reuters I/B/E/S.

GAAP net profit was unchanged at $2.5 billion. GAAP earnings per share were 52 cents, up 6 percent from the year-ago period. Its adjusted earnings per share were 65 cents, shy of 66 cents expected by analysts.

Shares in the software company fell 8 percent to $32.95 after hours, from a close of $35.765 on Nasdaq.

(Reporting by Noel Randewich; Editing by Richard Chang)